139 related articles for article (PubMed ID: 15882270)
21. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011
[TBL] [Abstract][Full Text] [Related]
22. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
Gregersen H; Zhao J; Lu X; Zhou J; Falk E
Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
[TBL] [Abstract][Full Text] [Related]
23. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
25. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes.
't Hoen PA; Van der Lans CA; Van Eck M; Bijsterbosch MK; Van Berkel TJ; Twisk J
Circ Res; 2003 Aug; 93(3):262-9. PubMed ID: 12829615
[TBL] [Abstract][Full Text] [Related]
26. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
[TBL] [Abstract][Full Text] [Related]
27. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice.
Bentzon JF; Skovenborg E; Hansen C; Møller J; de Gaulejac NS; Proch J; Falk E
Circulation; 2001 Mar; 103(12):1681-7. PubMed ID: 11273997
[TBL] [Abstract][Full Text] [Related]
28. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
29. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression.
Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E
Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015
[TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.
Rodrigues SD; França KC; Dallin FT; Fujihara CK; Nascimento AJ; Pecoits-Filho R; Nakao LS
Life Sci; 2015 Jan; 121():110-6. PubMed ID: 25500303
[TBL] [Abstract][Full Text] [Related]
31. [Rosiglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice].
Zhao QM; Yan D; Song AL; Wang W; Shi Q; Wang LY; Chen D; Fang W; Wu Y; Xu JP; Chen X; Chen TJ; Mi SH; Lü SZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):399-404. PubMed ID: 15932692
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
34. Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Dechaux M; Massy ZA; Phan O; Mothu N; Lacour B; Drueke TB; Muntzel M
Atherosclerosis; 2005 Jun; 180(2):271-6. PubMed ID: 15910852
[TBL] [Abstract][Full Text] [Related]
35. Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure.
Nikolov IG; Joki N; Nguyen-Khoa T; Ivanovski O; Phan O; Lacour B; Drüeke TB; Massy ZA; Dos Reis LM; Jorgetti V; Lafage-Proust MH
Bone; 2010 Jul; 47(1):156-63. PubMed ID: 20406703
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
Chyu KY; Babbidge SM; Zhao X; Dandillaya R; Rietveld AG; Yano J; Dimayuga P; Cercek B; Shah PK
Circulation; 2004 May; 109(20):2448-53. PubMed ID: 15136500
[TBL] [Abstract][Full Text] [Related]
37. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
38. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice].
Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623
[TBL] [Abstract][Full Text] [Related]
39. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
40. [Relationship between accelerated artherosclerosis and Treg/Teff balance in uremic apoE-/- mice].
Shen Y; Yuan ZY; Liu Y; Xiao Y; Wu Y; Zhao Y; Tian YL; Liu WM; Wang LJ; Liang X; Chen T; Geng T
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):214-8. PubMed ID: 20159683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
